Detalles de la búsqueda
1.
Hematology and oncology clinical care during the coronavirus disease 2019 pandemic.
CA Cancer J Clin
; 70(5): 349-354, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32662880
2.
Acute hemolytic anemia after hematopoietic stem cell transplantation: An unusual invader.
Am J Hematol
; 98(8): 1341-1342, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36746647
3.
Impact of a Multiplexed Polymerase Chain Reaction Panel on Identifying Diarrheal Pathogens in Hematopoietic Cell Transplant Recipients.
Clin Infect Dis
; 71(7): 1693-1700, 2020 10 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-31687767
4.
Outcomes of Allogeneic Stem Cell Transplant for Elderly Patients with Hematologic Malignancies.
Biol Blood Marrow Transplant
; 26(4): 789-797, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31891814
5.
Bortezomib and Immune Globulin Have Limited Effects on Donor-Specific HLA Antibodies in Haploidentical Cord Blood Stem Cell Transplantation: Detrimental Effect of Persistent Haploidentical Donor-Specific HLA Antibodies.
Biol Blood Marrow Transplant
; 25(2): e60-e64, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30661542
6.
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 25(2): 369-381, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30292744
7.
Adoptive Immunotherapy with Cord Blood for the Treatment of Refractory Acute Myelogenous Leukemia: Feasibility, Safety, and Preliminary Outcomes.
Biol Blood Marrow Transplant
; 25(3): 466-473, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30414955
8.
A Phase II Multicenter Study of the Addition of Azacitidine to Reduced-Intensity Conditioning Allogeneic Transplant for High-Risk Myelodysplasia (and Older Patients with Acute Myeloid Leukemia): Results of CALGB 100801 (Alliance).
Biol Blood Marrow Transplant
; 25(10): 1984-1992, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31212080
9.
Colonization With Levofloxacin-resistant Extended-spectrum ß-Lactamase-producing Enterobacteriaceae and Risk of Bacteremia in Hematopoietic Stem Cell Transplant Recipients.
Clin Infect Dis
; 67(11): 1720-1728, 2018 11 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-29701766
10.
Granulocyte Colony-Stimulating Factor Use after Autologous Peripheral Blood Stem Cell Transplantation: Comparison of Two Practices.
Biol Blood Marrow Transplant
; 24(2): 288-293, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29061534
11.
Combined Haploidentical and Umbilical Cord Blood Allogeneic Stem Cell Transplantation for High-Risk Lymphoma and Chronic Lymphoblastic Leukemia.
Biol Blood Marrow Transplant
; 24(2): 359-365, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29128555
12.
Reduced-Intensity Allogeneic Transplant for Acute Myeloid Leukemia and Myelodysplastic Syndrome Using Combined CD34-Selected Haploidentical Graft and a Single Umbilical Cord Unit Compared with Matched Unrelated Donor Stem Cells in Older Adults.
Biol Blood Marrow Transplant
; 24(5): 997-1004, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29288821
13.
Final results from a defibrotide treatment-IND study for patients with hepatic veno-occlusive disease/sinusoidal obstruction syndrome.
Br J Haematol
; 181(6): 816-827, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29767845
14.
Safety and efficacy of plerixafor dose escalation for the mobilization of CD34+ hematopoietic progenitor cells in patients with sickle cell disease: interim results.
Haematologica
; 103(5): 770-777, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29419425
15.
Validating and implementing the use of an infusion pump for the administration of thawed hematopoietic progenitor cells-a single-institution experience.
Transfusion
; 58(2): 339-344, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29193156
16.
Defibrotide for Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome: Interim Results from a Treatment IND Study.
Biol Blood Marrow Transplant
; 23(6): 997-1004, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28285079
17.
A Phase I Trial of High-Dose Lenalidomide and Melphalan as Conditioning for Autologous Stem Cell Transplantation in Relapsed or Refractory Multiple Myeloma.
Biol Blood Marrow Transplant
; 23(6): 930-937, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28285081
18.
Comparison of Subcutaneous versus Intravenous Alemtuzumab for Graft-versus-Host Disease Prophylaxis with Fludarabine/Melphalan-Based Conditioning in Matched Unrelated Donor Allogeneic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 22(3): 456-61, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26524732
19.
DAS181 for Treatment of Parainfluenza Virus Infections in Hematopoietic Stem Cell Transplant Recipients at a Single Center.
Biol Blood Marrow Transplant
; 22(5): 965-70, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26904972
20.
Frequency and Risk Factors Associated with Cord Graft Failure after Transplant with Single-Unit Umbilical Cord Cells Supplemented by Haploidentical Cells with Reduced-Intensity Conditioning.
Biol Blood Marrow Transplant
; 22(6): 1065-1072, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26912055